Kevin Vernarec

Kevin Vernarec is the SVP, Global Head of Late Phase Clinical Development at QPS. Kevin has over 20 years of experience in the clinical research industry. Prior to joining QPS, Kevin was the Vice President of Operational Excellence at TKL Research from 2014 to 2017. Kevin has also held leadership positions at ICON Clinical Research, Symbiance, and Pfizer. In addition to their work in the clinical research industry, Kevin is also the owner of Classical Clinical Research, LLC.

Kevin Vernarec earned a Bachelor of Science (B.S.) degree in Biology from Penn State University.

A direct report to Kevin Vernarec is and Robert Wronski - Senior Director, Head of EU Late Phase Clinical Development. They work with Birgit Hutter-Paier - Senior Director, Head of Neuropharmacology, Brendon Bourg - VP, GM, Missouri, and Ben Hsu - CAO & GM, QPS LLC. Kevin Vernarec reports to Ben Chien, Chairman, President & CEO.